As a cornerstone of human gut health, Bifidobacterium infantis (B. infantis) represents a critical growth sector in the global nutraceutical industry. ShineHerb Biotech leverages advanced fermentation technologies to provide high-purity, stable, and highly viable probiotic strains. Our production processes ensure that the specific metabolic activities and colonization efficiencies of B. infantis are preserved, meeting the rigorous standards required by infant formula and immune-health supplement manufacturers worldwide.
Rising consumer awareness of the gut-brain axis is driving demand for specific strains like B. infantis, which are essential for digestive development and immune modulation.
Global procurement trends favor manufacturers who can guarantee "colony-forming unit" (CFU) counts that survive the transition from raw material to shelf-stable finished goods.
Our "Factory 4.0" approach integrates automated monitoring to ensure batch-to-batch consistency and high supply chain transparency for international partners.
We utilize advanced micro-encapsulation technology that protects the live bacteria during production, shipping, and shelf-storage, ensuring consistent high-activity counts upon delivery.
Yes. Every shipment includes a comprehensive COA, and we support our clients with full documentation (MSDS, Specification Sheets, and Stability Reports) required for FDA, EFSA, or local regulatory compliance.
